Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$2.1 million.

  • Coya Therapeutics' Profit After Tax rose 4738.59% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.4 million, marking a year-over-year decrease of 7228.97%. This contributed to the annual value of -$14.9 million for FY2024, which is 8629.31% down from last year.
  • Per Coya Therapeutics' latest filing, its Profit After Tax stood at -$2.1 million for Q3 2025, which was up 4738.59% from -$6.1 million recorded in Q2 2025.
  • Over the past 5 years, Coya Therapeutics' Profit After Tax peaked at $1.3 million during Q4 2023, and registered a low of -$7.3 million during Q1 2025.
  • Over the past 3 years, Coya Therapeutics' median Profit After Tax value was -$3.1 million (recorded in 2023), while the average stood at -$3.5 million.
  • As far as peak fluctuations go, Coya Therapeutics' Profit After Tax crashed by 33031.86% in 2024, and later skyrocketed by 4738.59% in 2025.
  • Quarter analysis of 3 years shows Coya Therapeutics' Profit After Tax stood at $1.3 million in 2023, then tumbled by 330.32% to -$2.9 million in 2024, then increased by 27.44% to -$2.1 million in 2025.
  • Its Profit After Tax stands at -$2.1 million for Q3 2025, versus -$6.1 million for Q2 2025 and -$7.3 million for Q1 2025.